Dileep Mangsuli appointed as Chairman of CTSI, South Asia
Cancer Treatment Services International (CTSI) is pleased to announce the appointment of Mr. Dileep Mangsuli as Chairman. Mr. Mangsuli will take on this strategic leadership role while continuing to serve as Senior Vice President at Siemens Healthineers.
With a distinguished career spanning over two decades, Mr. Mangsuli has been instrumental in pioneering advancements in digital healthcare technologies. At Siemens Healthineers, he has led initiatives focusing on artificial intelligence (AI), digital twins, and immersive technologies to enhance diagnostic precision and patient care. His leadership has been pivotal in establishing collaborative efforts, such as the AI in Precision Medicine lab at the Indian Institute of Science, aimed at developing open-source AI tools for neuroimaging analysis.
At CTSI, Mr. Mangsuli will oversee the strategic direction and operational excellence of CTSI's South Asia network, which includes the American Oncology Institute, Citizens Specialty Hospital, and Ampath Labs. His appointment aligns with CTSI's commitment to integrating cutting-edge digital solutions to enhance cancer care and patient outcomes across the region.
Dileep Mangsuli, Chairman, CTSI-South Asia said, "I am pleased to join CTSI at such a transformative phase in its journey. The industry is witnessing a profound transformation, driven by the need for strategic, results-focused solutions that enhance operational efficiency and accelerate digital adoption. CTSI’s dedication to integrating advanced technology with clinical excellence places it at the forefront of transforming healthcare in South Asia. I am excited to bring my experience in digital healthcare to support the organization’s strategic growth and enhance access to high-quality healthcare across the region. Alongside the team, I remain committed to setting new standards in clinical outcomes and patient at the core of everything we do”
Got a story that Healthcare Executive should dig into? Shoot it over to arunima.rajan@hosmac.com—no PR fluff, just solid leads.